Cargando…
Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma
RCC usually develops and progresses asymptomatically and, when detected, it is frequently at advanced stages and metastatic, entailing a dismal prognosis. Therefore, there is an obvious demand for new strategies enabling an earlier diagnosis. The importance of metabolic rearrangements for carcinogen...
Autores principales: | Monteiro, Márcia S., Barros, António S., Pinto, Joana, Carvalho, Márcia, Pires-Luís, Ana S., Henrique, Rui, Jerónimo, Carmen, Bastos, Maria de Lourdes, Gil, Ana M., Guedes de Pinho, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114559/ https://www.ncbi.nlm.nih.gov/pubmed/27857216 http://dx.doi.org/10.1038/srep37275 |
Ejemplares similares
-
GC‐MS metabolomics‐based approach for the identification of a potential VOC‐biomarker panel in the urine of renal cell carcinoma patients
por: Monteiro, Márcia, et al.
Publicado: (2017) -
GC-MS Metabolomics Reveals Distinct Profiles of Low- and High-Grade Bladder Cancer Cultured Cells
por: Rodrigues, Daniela, et al.
Publicado: (2019) -
Advances and Perspectives in Prostate Cancer Biomarker Discovery in the Last 5 Years through Tissue and Urine Metabolomics
por: Lima, Ana Rita, et al.
Publicado: (2021) -
Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine
por: Lima, Ana Rita, et al.
Publicado: (2019) -
Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies
por: Lima, Ana Rita, et al.
Publicado: (2016)